-
June 25: The Week in Cancer NewsA reporter discusses the elevated risk for early-onset colorectal cancer in Black men, and a study shows that women are underrepresented in cancer clinical trials.
by Kate Yandell
-
June 18: The Week in Cancer NewsA study compares the benefits of fixed doses of immunotherapy compared to weight-based doses, and the Food and Drug Administration approves a targeted therapy for a rare disorder called systemic mastocytosis.
by Bradley Jones
-
June 11: The Week in Cancer NewsTriplet therapy shows promise for prostate cancer that was metastatic at diagnosis, and Americans report inadequate knowledge of palliative care.
by Marci A. Landsmann
-
June 4: The Week in Cancer NewsA targeted therapy improves disease-free survival when given to people with certain hereditary mutations after breast cancer surgery, and the Food and Drug Administration approves a new lung cancer treatment targeting a mutated form of the KRAS protein.
by Kevin McLaughlin
-
May 28: The Week in Cancer NewsA study finds that many people with solid tumors mount an antibody response following COVID-19 vaccination, and the Food and Drug Administration approves the first targeted therapy for a rare lung cancer subtype.
by Kate Yandell
-
May 21: The Week in Cancer NewsThe U.S. Preventive Services Task Force lowers its recommended age to begin colorectal cancer screening to 45, and a major multiple myeloma study begins in Iceland.
by Bradley Jones
-
May 14: The Week in Cancer NewsResearchers report disappointing results about ovarian cancer screening, and cancer patients with impaired immune function feel uncertain about protection offered by COVID-19 vaccination.
by Marci A. Landsmann
-
May 7: The Week in Cancer NewsA Food and Drug Administration panel recommends withdrawing approvals for two treatment indications for immunotherapy drugs, and the U.S. Preventive Services Task Force recommend against vitamin E and beta-carotene for cancer prevention.
by Kevin McLaughlin
-
April 30: The Week in Cancer NewsPresident Biden resurfaces a proposal for a new health care agency, and the Food and Drug Administration approves a treatment for large B-cell lymphoma.
by Bradley Jones
-
April 23: The Week in Cancer NewsAnti-racism activist and historian Ibram X. Kendi opens up about his stage IV colon cancer treatment, and the FDA approves an immunotherapy drug for endometrial cancer
by Marci A. Landsmann
The ‘Your Friends & Neighbors’ actress explains how her diagnosis challenged many of her assumptions about breast cancer.
by Darlene Dobkowski
Why I Participated in a Clinical TrialWhen doctors told Yvonne McLean Florence she was eligible to participate in a research trial testing an experimental drug, she joined. She wants more people to have the same opportunity.
by Yvonne McLean Florence
Targeted Therapy Improves Pancreatic Cancer SurvivalA recently approved drug that targets RAS proteins meaningfully improves outcomes for people with this difficult-to-treat cancer.
by Sandra Gordon
Bring On the WavesA surfer’s love for the ocean guides her through breast cancer treatment and beyond.
by Cameron Walker
-
AACR OMB Statement and Call to ActionThe AACR is deeply concerned that proposed OMB regulations would disrupt federal research grant giving, severely weakening a program that has supported American medical innovation for decades.
-
AACR Cancer Disparities Progress ReportThe AACR Cancer Disparities Progress Report 2026 highlights recent progress in reducing cancer disparities and emphasizes the continued need for transformative research.
Cancer Research at a Crossroads
